NCT01817218View on ClinicalTrials.gov

Feasibility and Safety and Evaluation of the Potential Efficacy of Autologous Platelet-rich Plasma in the Treatment of Vascular Venous Ulcers

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

April 30, 2015

Conditions
Chronic Ulcer
Interventions
DRUG

Platelet Rich Plasma

DEVICE

Osakidetza protocol

"Patients in the control group will be treated following the recommendations of the Ezkerraldea-Enkarterri Health Region, that is, using a moist healing environment (as described in Uso racional de los productos de cura en ambiente húmedo. Plan de formación continuada de Osakidetza, 2011).~The type of material used to treat and dress the wound will be chosen after the assessment of the wound and surrounding skin, type and quantity of exudate and whether there are signs of infection. Wound care will be carried out every 48-72 hours, as is the current usual practice."

Trial Locations (1)

48920

Comarca Enkarterri Ezkerraldea, Portugalete

All Listed Sponsors
lead

Basque Health Service

OTHER_GOV

NCT01817218 - Feasibility and Safety and Evaluation of the Potential Efficacy of Autologous Platelet-rich Plasma in the Treatment of Vascular Venous Ulcers | Biotech Hunter | Biotech Hunter